Integrin αvβ6 is considered a promising molecular imaging target because it is significantly up-regulated in various types of cancers and correlates with the survival time of patients. MR imaging has advantages of non-invasive, non-radioactive, high soft-tissue contrast, and multiparameter imaging. Therefore, this study synthesized an integrin αvβ6-targeted nanoparticle probe for MR molecular imaging. Our experiments showed that novel targeted nanoparticles can specifically bind with integrin αvβ6 overexpressed cells in vitro and in vivo, presenting potential applications in the fields of αvβ6-positive tumor targeted MR molecular imaging.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords